Blueprint Medicines
BPMC
#2452
Rank
S$7.94 B
Marketcap
$125.08
Share price
-4.87%
Change (1 day)
7.17%
Change (1 year)

Revenue for Blueprint Medicines (BPMC)

Revenue in 2024 (TTM): S$0.57 Billion

According to Blueprint Medicines 's latest financial reports the company's current revenue (TTM ) is S$0.59 Billion. In 2023 the company made a revenue of S$0.32 Billion an increase over the revenue in the year 2022 that were of S$0.27 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Blueprint Medicines from 2015 to 2024

201620192022$0.2B$0.4B$0.6B$0.8B$1B$1.2Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) S$0.57 B74.97%
2023 S$0.32 B20.41%
2022 S$0.27 B12.36%
2021 S$0.24 B-76.82%
2020 S$1.05 B1071.03%
2019 S$89.67 M47.43%
2018 S$60.82 M112.24%
2017 S$28.65 M-28.7%
2016 S$40.19 M149.26%
2015 S$16.12 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$12.22 M-97.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.96 B 63.76%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.23 B-60.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.15 B-74.04%๐Ÿ‡บ๐Ÿ‡ธ USA